Rentokil Initial (RTO) Equity Ratio (2021 - 2025)
On a quarterly basis, Equity Ratio rose 17484.56% to 70.46 in Q4 2025 year-over-year; TTM through Dec 2025 was 70.46, a 49201.91% increase, with the full-year FY2025 number at 70.46, down 2.82% from a year prior.
Rentokil Initial (RTO) has 5 years of Equity Ratio data on record, last reported at 70.46 in Q4 2025.
- Equity Ratio reached 70.46 in Q4 2025 per RTO's latest filing, up from 0.4 in the prior quarter.
- Over the last five years, Equity Ratio for RTO hit a ceiling of 70.46 in Q4 2025 and a floor of 0.3 in Q4 2021.
- A 5-year average of 12.06 and a median of 0.38 in 2024 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: rose 5.11% in 2023, then soared 17484.56% in 2025.
- Tracing RTO's Equity Ratio over 5 years: stood at 0.3 in 2021, then rose by 16.81% to 0.35 in 2022, then grew by 5.11% to 0.37 in 2023, then rose by 9.04% to 0.4 in 2024, then skyrocketed by 17484.56% to 70.46 in 2025.
- Business Quant data shows Equity Ratio for RTO at 70.46 in Q4 2025, 0.4 in Q4 2024, and 0.37 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | 0.16 |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | 70.46 |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 0.47 |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 0.92 |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 0.45 |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | 0.37 |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 0.45 |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 0.24 |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 0.42 |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | 0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 70.46 |
| Dec 31, 2024 | 0.40 |
| Dec 31, 2023 | 0.37 |
| Jun 30, 2023 | 0.47 |
| Dec 31, 2022 | 0.35 |
| Dec 31, 2021 | 0.30 |